Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
US Food and Drug Administration, Silver Spring, Maryland.
Poonam
P
Mishra
US Food and Drug Administration, Jefferson, Arkansas. Electronic address: minjun.chen@fda.hhs.gov.
Minjun
M
Chen
D000998:Antiviral Agents / Q000009:adverse effects* / Q000737:chemistry; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D015233:Models, Statistical; D018570:Risk Assessment; D012307:Risk Factors
D000998:Antiviral Agents